Plasma proteins, also termed as Serum Proteins or Blood Proteins, are proteins present in blood plasma. They serve different functions, including transport of lipids, hormones, vitamins and minerals in the circulatory system and the regulation of acellular activity and functioning of the immune system. Other blood proteins act as enzymes, complement components, protease inhibitors or kinin precursors.
The Chinese plasma protein market is heavily regulated and the market is characterized by supply shortages that provide lucrative opportunities to the leading companies operating in the sector. The main driving force of Plasma Proteins market in China is high demand of albumin in China, rapidly growing IVIG market, and rising expenditure on China healthcare sector.
Complete report available at http://www.marketreportsonline.com/420314.html.
- China Biologic Product
- Hualan Biological Engineering
- Beijing Tiantan
- Shanghai RAAS Blood Products
- CSL Ltd.
The report titled “China Plasma Protein Market: Trends and Opportunities (2015-2019)” analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Plasma Protein market in China. The report elucidates facts on the China Plasma Proteins Market as supplemented by the latest available statistics. The report gives valuable insight into technology used in China Plasma Proteins market, its demand and supply. It also profiles and analyzes the leading five companies operating in this industry with latest data and a brief overview of their business and finance structure along with a brief discussion of their future business strategies. In the report, we also try to study the growth pattern in the production and revenue earned by the China Plasma Protein companies and the latest trends concerning China Plasma Proteins. Most importantly, we have analyzed the current market size and project future market size of the overall China Plasma Protein market for the years to come.
Purchase a copy of “Plasma Protein Market” research report at USD 700 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=420314.
Although, China Plasma Protein market is growing, there are some challenges that need to be addressed. These challenges include less expansion of Plasma Protein market, strict regulations such as ban on import of IVIG and FactorVIII and changes in China’s political and economic stability. Despite challenges like stringent regulations, ensuring adequate supply of human plasma and high cost of treatment in China Blood Plasma Proteins market, the Chinese IVIG market is all set to witness high growth in the coming years as a result of multiple factors such as growing ageing population, increasing number of patients with bleeding disorder and rising healthcare expenditure.
Major points from Table of Contents (http://www.marketreportsonline.com/420314-toc.html) are listed below:1. Executive Summary
2. Introduction to Plasma Protein Industry
2.1. History of Plasma Proteins Fractionation
2.2. Types of Plasma Proteins
2.3. Clinical uses of Plasma Protein Products
2.4. Concept of Plasma Economics
2.5. Detailed Description of Plasma Collection Method
3. Global Blood Plasma Market: Size and Growth (2010-2019)
4. China Plasma Protein Market: An Analysis
4.1 Chinese Plasma Protein Market Segmentation
4.2 Chinese IVIG Market: Actual & Forecast
4.3 Chinese Factor VIII Market: Actual & Forecast
5. China Plasma Protein Market Share: An Analysis
5.1 China Blood Plasma Market Share: By Revenue
5.2 China Plasma Proteins Market Share: Segments
5.3 China Albumin Market Share: By Consumption
5.4 China Plasma Proteins Market Share: By Pharmaceutical Sales
6. China Plasma Protein Market: Facts and Statistical Analysis
6.1 China Plasma Protein Market Statistics Snapshot
6.2 China per Capita Expenditure on Medical Treatment
6.3 China Plasma Market Regulations
7. China Plasma Protein Market Dynamics
7.1 Growth Drivers
7.2 Market Trends
8. Competitive Landscape: China Plasma Protein Market
China’s leading companies and their comparative analysis
9. Company Profiles: China Plasma Protein Market
List of Figures
Other Related Reports on pharmaceuticals Market:
Global Pulmonary Arterial Hypertension (PAH)) Market: Trends and Opportunities (2015-2019)( http://www.marketreportsonline.com/418123.html) The report provides detailed analysis of the global PAH market sizing and growth by type for the period 2010-2014. The market is further segment by drug mechanism and different dosage forms.
Global Vitamin and Supplements Market: Trends & Opportunities (2015-2019) (http://www.marketreportsonline.com/416739.html) As the proportion of ageing population in the world is increasing and as the lifestyles are modifying, the nutritional intake of people is decreasing. In the growing age of fast-food, to maintain the nutritional needs vitamin supplements have become a necessity. More than 60% of the population consumes vitamins on daily basis. Vitamins are of two types depending upon how they are absorbed by the body, namely water-soluble and fat-soluble.
US Thyroid Cancer Market: Trends and Opportunities (2015 - 2019) (http://www.marketreportsonline.com/404148.html) Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy.
Global Biosimilar Market Trends & Opportunities: 2015 Edition (http://www.marketreportsonline.com/395635.html) The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report.
Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19) (http://www.marketreportsonline.com/396022.html) Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries.
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
1 South Dearborn Street,
21st Floor , Chicago, Illinois, 60603, USA.
Tel: + 1 888 391 5441